Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers fourth milestone payment for this ...
Allschwil, Switzerland, October 10, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the …